February 20-21, 2018

Boston, USA




The World CNS: Neurodegenerative Diseases Summit 2017 is a unique meeting of pharma, biotech and academia, designed to help scientists and business leaders in those organisations overcome the barriers to translational research in neurodegenerative disease.

Delegates attend the summit actively seeking outside expertise, collaborators and partners to help them with:

  • Accelerating pre-clinical research with translatable in vitro and in vivo models of neurodegenerative disease with more efficient safety and efficacy testing
  • Streamlining and optimising clinical trial design, managing the rigorous approval standards demanded in neurodegenerative trials and accessing appropriate patient populations
  • Improving the ability to more quickly and precisely show disease modification both in pre-clinical models and clinical drug development
  • Identifying novel, innovative approaches to delivering targeted therapeutics safely and efficiently across the blood-brain barrier

Why sponsor?

  • Showcase your therapeutic area expertise and establish your credibility as a research partner in neurodegenerative disease
  • Educate the industry about your products or services as part of our expert speaker faculty, or by demonstrating in our exhibition
  • Network with new clients and cement existing relationships via our speed networking, personal introductions and our multiple industry wide touch points
  • Position yourself as a market leader by aligning your brand with the first summit dedicated to translational research and neurodegenerative drug development

ArrowFor more information on how you can be involved, contact our Commercial Manager, Mo Langhi at [email protected]